🇺🇸 FDA
Pipeline program

Cabiralizumab

FPA008-003

Phase 1 mab completed

Quick answer

Cabiralizumab for Advanced Solid Tumors is a Phase 1 program (mab) at Prime Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Prime Medicine
Indication
Advanced Solid Tumors
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials